Jaguar Health Announces Inducement Grants Under Nasdaq Rule

On October 24, 2025, Jaguar Health, Inc. (NASDAQ: JAGX) announced the grant of restricted stock units (RSUs) to three new employees. Effective October 20, 2025, New Employee 1 and New Employee 2 received 600 RSUs each, while New Employee 3 was granted 300 RSUs.

The RSUs are scheduled to vest over one year, beginning on each employee's hiring date. These stock grants were crucial incentives for the new hires and were approved by Jaguar's Compensation Committee. The vesting conditions require continued service with Jaguar Health.

Jaguar Health, a commercial-stage pharmaceutical company, focuses on developing plant-based medicines for gastrointestinal distress in humans and animals. These inducement grants aim to attract and retain talent essential for the company's growth and innovation.